These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 3328502

  • 1. [Evaluation of a monoclonal antibody-based enzyme immunoassay (IQ(Bio) PAP-AELIA kit) for prostatic acid phosphatase].
    Koshida K, Naito K, Hisazumi H.
    Hinyokika Kiyo; 1987 Oct; 33(10):1703-7. PubMed ID: 3328502
    [Abstract] [Full Text] [Related]

  • 2. [Prostatic acid phosphatase by enzymeimmunoassay].
    Masukagami T, Ando K, Shimazaki J.
    Hinyokika Kiyo; 1984 Nov; 30(11):1691-5. PubMed ID: 6084950
    [Abstract] [Full Text] [Related]

  • 3. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
    Akimoto S, Ohki T, Ichikawa T, Akakura K, Shimazaki J.
    Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
    [Abstract] [Full Text] [Related]

  • 4. [The significance of serum gamma-seminoprotein in prostatic cancer].
    Ishikawa S, Tozuka K, Ishiyama S, Goto K, Ohba S, Tokue A, Yonese Y, Kamachi S, Sakurabayashi I, Kawai T.
    Hinyokika Kiyo; 1985 Jun; 31(6):961-7. PubMed ID: 2414979
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer].
    Akimoto S, Akakura K, Shimazaki J.
    Hinyokika Kiyo; 1988 Dec; 34(12):2143-8. PubMed ID: 2467543
    [Abstract] [Full Text] [Related]

  • 6. [Clinical application of immunoenzyme assay for prostatic acid phosphatase].
    Yoshida K, Sato S, Nishimura T, Akimoto M.
    Hinyokika Kiyo; 1989 Oct; 35(10):1819-22. PubMed ID: 2692448
    [Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of a new kit (IMX PA Dainapack) for detection of serum prostate specific antigen].
    Machida T, Ohishi Y, Wada T, Akimoto S, Shimazaki J, Oda H, Yokoyama M, Tsukada T, Nakayama T, Akiyama A.
    Hinyokika Kiyo; 1993 Oct; 39(10):977-84. PubMed ID: 7505519
    [Abstract] [Full Text] [Related]

  • 8. [Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer].
    Watanabe M, Kitamura Y, Komatsubara S, Sakata Y.
    Hinyokika Kiyo; 1988 Dec; 34(12):2135-41. PubMed ID: 2467542
    [Abstract] [Full Text] [Related]

  • 9. [Prostate specific antigen in serum of the patients with prostatic cancer].
    Akimoto S, Akakura K, Fuse H, Shimazaki J.
    Hinyokika Kiyo; 1988 Apr; 34(4):636-42. PubMed ID: 2456678
    [Abstract] [Full Text] [Related]

  • 10. [The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer].
    Hamami G.
    Hinyokika Kiyo; 1983 Oct; 29(10):1231-45. PubMed ID: 6085711
    [Abstract] [Full Text] [Related]

  • 11. [Value of serum PSA and PAP measurement with newly developed latex turbidimetric immunoassay].
    Akino H, Tsuka H, Okada K, Tsuchiya Y, Matsubara M, Arimura K.
    Hinyokika Kiyo; 1995 Jun; 41(6):439-45. PubMed ID: 7544063
    [Abstract] [Full Text] [Related]

  • 12. [Prostatic acid phosphatase and prostatic specific antigen measured by immunoenzyme assay].
    Fuse H, Akimoto S, Shimazaki J.
    Hinyokika Kiyo; 1986 Dec; 32(12):1813-9. PubMed ID: 2435130
    [Abstract] [Full Text] [Related]

  • 13. [Clinical evaluation of serum prostatic acid phosphatase assay based on the immunoenzymatic method (TZR-516)].
    Ikemoto I, Machida T, Oishi Y, Onishi T, Shirai T, Imanaka K.
    Hinyokika Kiyo; 1989 Sep; 35(9):1639-42. PubMed ID: 2479240
    [Abstract] [Full Text] [Related]

  • 14. [Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer].
    Arai Y, Yoshki T, Okada K, Yoshida O, Yamamoto N, Sakatoku J, Sugimura Y, Kawamura J.
    Hinyokika Kiyo; 1989 Sep; 35(9):1519-28. PubMed ID: 2479237
    [Abstract] [Full Text] [Related]

  • 15. [Improved diagnostic evaluation of prostatic neoplasms using radioimmunoassay for prostatic acid phosphatase].
    Gaca A, Panitz N.
    Helv Chir Acta; 1981 Aug; 48(3-4):465-6. PubMed ID: 7287485
    [Abstract] [Full Text] [Related]

  • 16. [Clinical evaluation of serum gamma-seminoprotein in patients with prostatic cancer].
    Ishihara Y, Hiromoto Y, Higaki Y, Imamura K.
    Hinyokika Kiyo; 1989 Mar; 35(3):409-13. PubMed ID: 2660507
    [Abstract] [Full Text] [Related]

  • 17. [Clinical studies of gamma-seminoprotein in prostatic disease. I. Clinical evaluation of serum gamma-seminoprotein].
    Hasegawa S, Nakashima J, Nakashima Y, Nakamura S, Kimura S.
    Hinyokika Kiyo; 1987 Dec; 33(12):2055-8. PubMed ID: 3329453
    [Abstract] [Full Text] [Related]

  • 18. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein].
    Yoshiki T, Okada K, Oishi K, Yoshida O.
    Hinyokika Kiyo; 1987 Dec; 33(12):2044-9. PubMed ID: 2452559
    [Abstract] [Full Text] [Related]

  • 19. [Clinical evaluation of gamma-seminoprotein as a serum marker of prostate carcinoma].
    Sugimura Y, Sakurai M, Hioki T, Hayashi N, Yamakawa K, Tajima K, Tochigi H, Kawamura J.
    Hinyokika Kiyo; 1988 Dec; 34(12):2129-34. PubMed ID: 2467541
    [Abstract] [Full Text] [Related]

  • 20. Serum prostatic acid phosphatase (PAP): monoclonal enzyme-linked immunoassay compared to polyclonal radioimmunoassay.
    Taylor EH, Gadsden RH.
    Ann Clin Lab Sci; 1984 Dec; 14(1):21-6. PubMed ID: 6364952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.